NCNANasdaqPharmaceutical PreparationsFiscal year ends December 31
NuCana plc
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 19, 2026
$0.98−0.01 (-1.30%)
Close on Oct 19, 2026
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
0.0%
0M of 20.81B shares
Institutional holders
11
5 new, 2 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Antoine Papiernik | 4,987,975 | 5.10% | 13D (active) amendment | Feb 14, 2025 |
| Hugh S. Griffith | 2,829,961,890 | 12.00% | 13D (active) | Jun 20, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of NCNA | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| StoneX Group Inc. | 47,043 | 0.00% | $71.51K | New | 0.00% |
| Citadel Advisors LLC | 27,099 | 0.00% | $41.19K | +13,244 | 0.00% |
| Hrt Financial LP | 16,870 | 0.00% | $25 | New | 0.00% |
| Glass Jacobson Investment Advisors llc | 15,000 | 0.00% | $22.80K | – | 0.01% |
| Rhumbline Advisers | 4,698 | 0.00% | $7.14K | +976 | 0.00% |
| Citigroup Inc | 188 | 0.00% | $286 | New | 0.00% |
| Integrated Wealth Concepts LLC | 188 | 0.00% | $286 | New | 0.00% |
| Caitong International Asset Management Co., Ltd | 5 | 0.00% | $8 | +3 | 0.00% |
| Morgan Stanley | 2 | 0.00% | $3 | – | 0.00% |
| Acadian Asset Management LLC | 2 | 0.00% | $0 | – | 0.00% |
| SBI Securities Co., Ltd. | 1 | 0.00% | $2 | New | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 11 | 0M | 0.0% | 5 / 3 | 0 / 2 | 0M | 0M |
| Q1 2026 | 8 | 0M | 0.0% | 3 / 0 | 3 / 4 | 0M | 0M |
| Q4 2025 | 9 | 0M | 0.0% | 1 / 3 | 2 / 2 | 0M | 0M |
| Q3 2025 | 10 | 0M | 0.0% | 10 / 0 | 0 / 1 | 0M | 0M |
| Q2 2025 | 1 | 0M | 0.0% | 1 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of NCNA | Value | % of fund | As of |
|---|---|---|---|---|---|
| Blackstone Alternative Multi-Strategy Fund | -271 | -0.00% | -$412 | -0.00% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Hugh Griffith | Chief Executive Officer, Director | 1,000,000 | 0.00% | Mar 18, 2026 |
| Jeffrey D. Bloss | Chief Medical Officer | 47,136 | 0.00% | Jun 23, 2026 |
| Theresa Margaret Ms Bruce | Chief Operating Officer | – | – | Apr 16, 2026 |
| David James Harrison | Head of Translational Medicine | – | – | Mar 24, 2026 |
| Ian Alexander Webster | See Remarks | – | – | Mar 18, 2026 |
| Elliott M. Levy | Director | 13 | 0.00% | Jun 24, 2026 |
| Martin C.B. Mellish | Director | 28 | 0.00% | Mar 20, 2026 |
| Cyrille Leperlier | Director | – | – | Mar 18, 2026 |
| Andrew Martin Kay | Director | – | – | Mar 18, 2026 |